Darrell E. White, MD, is the founder of Skyvision Centers in Ohio. His blog for Ocular Surgery News will focus on issues related to dry eye disease.

BLOG: Our ‘better angels’ will prevail in time of COVID-19

March 18, 2020

Steven Pinker’s breakthrough, at least from a commercial standpoint, was a book about human nature entitled The Better Angels of Our Nature. In it, Pinker…

BLOG: Thank you for your support? That icky feeling when you know you’re being played

March 9, 2020

Twitter is generally a pretty fun place for me. Lots of learning, and some certifiably famous folks actually interact with the hoi polloi like yours truly. Sometimes…

BLOG: Do we need another topical antihistamine?

February 19, 2020

As long as I’m on the topic I got to thinking, do we really need another topical antihistamine drop? It’s a good time to ask because the rabble rousers at…

BLOG: Do we need another dry eye steroid?

February 6, 2020

Last month I wondered whether or not we need another branded cyclosporine A medication on the market to treat dry eye disease. Given the fact that the whole CsA game is…

BLOG: Do we need another branded cyclosporine A?

January 30, 2020

Remember when we all thought we were going to have three or four generic competitors for Restasis? And all of the changes we would see in the marketplace for…

BLOG: A new level of patient cost accounting

December 6, 2019

You will never hear me say that I’ve heard everything as an eye doctor. As in, “now I’ve heard everything.” Not from me. Uh-uh. Just today in the…

BLOG: The rhythm method in dry eye care

November 14, 2019

Got your attention with that headline, didn’t I? Actually, there really is something called “DryEyeRhythm.” It’s not a new dance move but an…

BLOG: Cequa enters, stage left — let the cyclosporine battles begin

October 29, 2019

Ladieeeees annnnnd gentlemen, in this corner (points to the right), the reigning champion, RESTASIS! And to my left, from the spunky upstart Sun Pharmaceuticals, the…

BLOG: All the cool kids have a J-code

September 4, 2019

Ophthalmologist No. 1: Hey! Did you hear that Dextenza got a J-code? Ophthalmologist No. 2: Wow! That’s terrific news.

BLOG: Why samples matter

August 26, 2019

Becky Sauerbrunn would rule the prescribing world if she was as good at setting priorities for big pharma as she was at winning 50/50 balls. You’re familiar with…